Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CORPORATE CONTRIBUTIONS IN EXCESS OF $50 MIL. TO NIH-FUNDED

Executive Summary

CORPORATE CONTRIBUTIONS IN EXCESS OF $50 MIL. TO NIH-FUNDED institutions should trigger a public disclosure requirement, a 12- member panel convened by the National Institutes of Health recommended at a Jan. 25-26 forum in Bethesda, Md. "NIH may very well want to know that a particular grantee has in place something of significant scope and size that could really affect the operations there, even though NIH might conclude after reviewing it that they're perfectly satisfied...that ultimately it raises no Bayh-Dole [Act] concern," commented panelist Jose Trias, Howard Hughes Medical Institute.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel